The results reported from Phase II of the first FDA-approved trial for the treatment of multiple sclerosis (MS) using stem cells are highly promising, suggesting that stem cells could be a viable treatment option to help improve the lives of those with the condition....
A new therapy, recently granted a UK Innovation Passport Designation, could help to improve treatment outcomes for Krabbe disease patients post-stem cell transplant. What is Krabbe disease? Krabbe disease is a rare genetic disorder affecting around 1 in every...
There’s exciting news from the University of Galway, where researchers are developing a new technique that they hope will improve the viability of stem cell treatments for Parkinson’s disease. The pioneering method, which involves the use of a substance...
